LONG-TERM OUTCOMES of COVID-19 VACCINATION in PATIENTS with RARE and COMPLEX CONNECTIVE TISSUE DISEASES: AN AD-INTERIM ANALYSIS of ERN-RECONNET VACCINATE STUDY
Annals of the Rheumatic Diseases
; 81:948-949, 2022.
Article
in English
| EMBASE | ID: covidwho-2008966
corticosteroid; immunosuppressive agent; vaccine; adult; advocacy group; antiphospholipid syndrome; cohort analysis; conference abstract; connective tissue disease; controlled study; coronavirus disease 2019; demographics; disease exacerbation; drug safety; European; fatigue; female; fever; headache; herpes simplex; human; informed consent; injection site reaction; major clinical study; male; middle aged; migraine aura; mixed connective tissue disease; myalgia; myositis; observational study; otitis; outcome assessment; prevalence; rash; Sjoegren syndrome; somnolence; stomatitis; systemic lupus erythematosus; systemic sclerosis; tinnitus; undifferentiated connective tissue disease; urticaria; vaccination; vertigo
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
Annals of the Rheumatic Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS